PULMONX CORPORATION Share-based Payment Arrangement, Amount Capitalized
PULMONX CORPORATION (LUNG) reported Share-based Payment Arrangement, Amount Capitalized of $300.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2026-08-04
- PULMONX CORPORATION share-based payment arrangement, amount capitalized for the quarter ending 2026-06-30 was $300.00K, a 40.00% decline year-over-year.
- PULMONX CORPORATION share-based payment arrangement, amount capitalized for the quarter ending 2026-03-31 was $300.00K, a 25.00% decline year-over-year.
- PULMONX CORPORATION share-based payment arrangement, amount capitalized for the quarter ending 2025-12-31 was $400.00K, a 0.00% change year-over-year.
- PULMONX CORPORATION share-based payment arrangement, amount capitalized for the quarter ending 2025-09-30 was $400.00K, a 0.00% change year-over-year.
- PULMONX CORPORATION share-based payment arrangement, amount capitalized for fiscal 2025 was $1.70M, a 0.00% change from fiscal 2024.
- PULMONX CORPORATION share-based payment arrangement, amount capitalized for fiscal 2024 was $1.70M, a 6.25% increase from fiscal 2023.
- PULMONX CORPORATION share-based payment arrangement, amount capitalized for fiscal 2023 was $1.60M.
- PULMONX CORPORATION share-based payment arrangement, amount capitalized for fiscal 2020 was $300.00K.
| Period end | Share-based Payment Arrangement, Amount Capitalized 3 month | Share-based Payment Arrangement, Amount Capitalized 6 month | Share-based Payment Arrangement, Amount Capitalized 9 month | Share-based Payment Arrangement, Amount Capitalized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $300.00K 10-Q · filed 2026-08-04 | $600.00K 10-Q · filed 2026-08-04 | $1.00M derived: sum of 3 quarters · filed 2026-08-04 | $1.40M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $300.00K 10-Q · filed 2026-05-04 | $700.00K derived: sum of 2 quarters · filed 2026-05-04 | $1.10M derived: sum of 3 quarters · filed 2026-05-04 | $1.60M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $800.00K derived: sum of 2 quarters · filed 2026-03-10 | $1.30M derived: sum of 3 quarters · filed 2026-08-04 | $1.70M 10-K · filed 2026-03-10 |
| 2025-09-30 | $400.00K 10-Q · filed 2025-11-12 | $900.00K derived: sum of 2 quarters · filed 2026-08-04 | $1.30M 10-Q · filed 2025-11-12 | $1.70M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $500.00K 10-Q · filed 2026-08-04 | $900.00K 10-Q · filed 2026-08-04 | $1.30M derived: sum of 3 quarters · filed 2026-08-04 | $1.70M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $400.00K 10-Q · filed 2026-05-04 | $800.00K derived: sum of 2 quarters · filed 2026-05-04 | $1.20M derived: sum of 3 quarters · filed 2026-05-04 | $1.70M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $800.00K derived: sum of 2 quarters · filed 2026-03-10 | $1.30M derived: sum of 3 quarters · filed 2026-03-10 | $1.70M 10-K · filed 2026-03-10 |
| 2024-09-30 | $400.00K 10-Q · filed 2025-11-12 | $900.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.30M 10-Q · filed 2025-11-12 | $1.70M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $500.00K 10-Q · filed 2025-08-01 | $900.00K 10-Q · filed 2025-08-01 | $1.30M derived: sum of 3 quarters · filed 2025-08-01 | $1.70M derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $400.00K 10-Q · filed 2025-05-02 | $800.00K derived: sum of 2 quarters · filed 2025-05-02 | $1.20M derived: sum of 3 quarters · filed 2025-05-02 | $1.60M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $800.00K derived: sum of 2 quarters · filed 2025-02-25 | $1.20M derived: sum of 3 quarters · filed 2025-02-25 | $1.60M 10-K · filed 2025-02-25 |
| 2023-09-30 | $400.00K 10-Q · filed 2024-11-01 | $800.00K derived: sum of 2 quarters · filed 2024-11-01 | $1.20M 10-Q · filed 2024-11-01 | |
| 2023-06-30 | $400.00K 10-Q · filed 2024-08-02 | $800.00K 10-Q · filed 2024-08-02 | ||
| 2020-12-31 | $300.00K 10-K · filed 2021-03-15 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-15 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |